FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p

(2018) Jinglin Zhang et al.   ONCOGENE

Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma

(2017) Axel Bex et al.   EUROPEAN UROLOGY

Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma

(2017) Pengyi Guo et al.   ONCOGENE

Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer

(2017) Sherry Bhalla et al.   Scientific Reports

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

Renal cell carcinoma

(2017) Paul Cairns   Cancer Biomarkers

Renal cancer

(2016) Umberto Capitanio et al.   LANCET

PD-L1 expression in nonclear-cell renal cell carcinoma

(2014) T. K. Choueiri et al.   ANNALS OF ONCOLOGY

TACC3 promotes epithelial–mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways

(2013) Geun-Hyoung Ha et al.   CANCER LETTERS

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer

(2013) Wei Wei et al.   JOURNAL OF CLINICAL INVESTIGATION

Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

(2013) L Chang et al.   Cell Death & Disease

EMT and Dissemination Precede Pancreatic Tumor Formation

(2012) Andrew D. Rhim et al.   CELL

A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer

(2011) A Bonnomet et al.   ONCOGENE